Pipobroman: Difference between revisions

	WikiDoc Resources for Pipobroman
Articles
Most recent articles on Pipobroman Most cited articles on Pipobroman Review articles on Pipobroman Articles on Pipobroman in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Pipobroman Images of Pipobroman Photos of Pipobroman Podcasts & MP3s on Pipobroman Videos on Pipobroman
Evidence Based Medicine
Cochrane Collaboration on Pipobroman Bandolier on Pipobroman TRIP on Pipobroman
Clinical Trials
Ongoing Trials on Pipobroman at Clinical Trials.gov Trial results on Pipobroman Clinical Trials on Pipobroman at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Pipobroman NICE Guidance on Pipobroman NHS PRODIGY Guidance FDA on Pipobroman CDC on Pipobroman
Books
Books on Pipobroman
News
Pipobroman in the news Be alerted to news on Pipobroman News trends on Pipobroman
Commentary
Blogs on Pipobroman
Definitions
Definitions of Pipobroman
Patient Resources / Community
Patient resources on Pipobroman Discussion groups on Pipobroman Patient Handouts on Pipobroman Directions to Hospitals Treating Pipobroman Risk calculators and risk factors for Pipobroman
Healthcare Provider Resources
Symptoms of Pipobroman Causes & Risk Factors for Pipobroman Diagnostic studies for Pipobroman Treatment of Pipobroman
Continuing Medical Education (CME)
CME Programs on Pipobroman
International
Pipobroman en Espanol Pipobroman en Francais
Business
Pipobroman in the Marketplace Patents on Pipobroman
Experimental / Informatics
List of terms related to Pipobroman

VisualWikitext

Latest revision as of 17:34, 7 April 2015

This image is provided by the National Library of Medicine.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pipobroman (trade names Vercite, Vercyte) is an anti-cancer drug that probably acts as an alkylating agent.

References

@@ Line 1: / Line 1: @@
-{{drugbox
+<div style="float: right;">
-| IUPAC_name = 3-bromo-1-[4-(3-bromopropanoyl) piperazin-1-yl]-propan-1-one
+[[File:Pipobroman.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div>
-| image = Pipobroman.svg
+__NOTOC__
-| CAS_number = 54-91-1
-| ATC_prefix = L01
-| ATC_suffix = AX02
-| ATC_supplemental =
-| PubChem = 4842
-| DrugBank = APRD00693
-| C=10 | H=16 | Br=2 | N=2 | O=2
-| molecular_weight = 356.054 g/mol
-| bioavailability =
-| protein_bound =
-| metabolism =
-| elimination_half-life =
-| excretion =
-| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
-| pregnancy_US = <!-- A / B / C / D / X -->
-| pregnancy_category =
-| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
-| legal_UK = <!-- GSL / P / POM / CD -->
-| legal_US = <!-- OTC / Rx-only -->
-| legal_status =
-| routes_of_administration =
-}}
 {{SI}}
-{{EH}}
+{{CMG}}
+==Overview==
+'''Pipobroman''' (trade names '''Vercite''', '''Vercyte''') is an anti-cancer drug that probably acts as an [[alkylating antineoplastic agent|alkylating agent]].
-==Overview==
+==References==
-'''Pipobroman''' is an [[alkylating antineoplastic agent|alkylating agent]].
+{{reflist|2}}
 {{Chemotherapeutic agents}}
-{{SIB}}
-[[Category:Chemotherapeutic agents]]
+[[Category:Organobromides]]
-{{WH}}
+[[Category:Amides]]
-{{WS}}
+[[Category:Piperazines]]
+[[Category:Drug]]

v t e Chemotherapeutic agents/Antineoplastic agents (L01)
Alkylating and alkylating-like agents	Nitrogen mustards: (Chlorambucil, Chlormethine, Cyclophosphamide, Ifosfamide, Melphalan, Bendamustine, Uramustine) Nitrosoureas:(Carmustine, Fotemustine, Lomustine, Streptozocin) Platinum (alkylating-like): (Carboplatin, Cisplatin, Oxaliplatin, Triplatin tetranitrate, Satraplatin) Alkyl sulfonates:(Busulfan, Treosulfan) Hydrazines:(Procarbazine, Dacarbazine, Temozolomide) Aziridines:(ThioTEPA)
Antimetabolites	Folic acid: (Aminopterin, Methotrexate, Pemetrexed, Raltitrexed). Purine:(Cladribine, Clofarabine, Fludarabine, Mercaptopurine, Pentostatin, Thioguanine) Pyrimidine:(Capecitabine, Cytarabine, Decitabine, Fluorouracil, Floxuridine, Gemcitabine)
Spindle poison/mitotic inhibitor	Taxane: (Docetaxel, Larotaxel, Paclitaxel). Vinca: (Vinblastine, Vincristine, Vindesine, Vinorelbine).
Cytotoxic/antitumor antibiotics	Anthracycline family: (Daunorubicin, Doxorubicin, Epirubicin, Idarubicin, Mitoxantrone, Pixantrone, Valrubicin) streptomyces (Actinomycin, Bleomycin, Mitomycin, Plicamycin) - Hydroxyurea
Topoisomerase inhibitors	Camptotheca: (Camptothecin, Topotecan, Irinotecan, Rubitecan), Podophyllum:(Etoposide, Teniposide)
CI monoclonal antibodies	Receptor tyrosine kinase (Cetuximab, Panitumumab, Trastuzumab) - CD20 (Rituximab, Tositumomab) - other (Alemtuzumab, Bevacizumab, Gemtuzumab)
Photosensitizers	Aminolevulinic acid, Methyl aminolevulinate, Porfimer sodium, Verteporfin
Tyrosine kinase inhibitors	Axitinib, Bosutinib, Cediranib, Dasatinib, Erlotinib, Gefitinib, Imatinib, Lapatinib, Lestaurtinib, Nilotinib, Semaxanib, Sorafenib, Sunitinib, Vandetanib
Cyclin-dependent kinase inhibitor	Seliciclib
Other	retinoids (Alitretinoin, Tretinoin), Fusion protein (Aflibercept) - Altretamine, Amsacrine, Anagrelide, Arsenic trioxide, Asparaginase (Pegaspargase), Bexarotene, Bortezomib, Celecoxib, Denileukin diftitox, Elesclomol, Estramustine, Irofulven, Ixabepilone, Masoprocol, Mitotane, Oblimersen, Testolactone, Tipifarnib, Trabectedin

Pipobroman: Difference between revisions

Latest revision as of 17:34, 7 April 2015

Overview

References

Navigation menu

Search